Biotech sector highly critical of Commission's patent stand, new survey reports
Marks & Clerk has released the findings of its most recent annual survey of executives working in the biotechnology industry. Among the highlights are:
• 72% of biotech executives fear the Commission’s enquiry into the pharmaceutical sector will…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.